ADRY SNOW: Open Payments
NPI 1346915410 · MCMINNVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 20 payments from 13 companies in 2025. Trend: 2023 $218 · 2024 $422 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $71 |
| Radius Health, Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novo Nordisk Inc | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $30 |
| ABIOMED | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
Products named: VRAYLAR, Tymlos, Kerendia, Veozah, REXULTI, CAPLYTA, JARDIANCE, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
